Attached files

file filename
EX-17 - EXHIBIT 17 - RIDGEFIELD ACQUISITION CORPv413900_ex17.htm

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

CURRENT REPORT

 

 

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 18, 2015

 

 

Ridgefield Acquisition Corp.

 

(Exact Name of Registrant as Specified in Charter)

 

Nevada   0-16335   84-0922701

(State or other Jurisdiction of Incorporation)

  (Commission File No.)  

(I.R.S. Employer Identification Number)

 

 

31248 Oak Crest Drive, Suite 110, Westlake Village, California 91361

 

(Address of Principal Executive Office) (Zip Code)

 

 

(805) 416-7054

 

(Registrant's telephone number including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

 

Item 5.02.Departure of Directors or Certain Officers; Election Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective June 18, 2015, Dr. Kenneth S. Schwartz resigned from the Board of Directors of Ridgefield Acquisition Corp. (the “Company”). Dr. Schwartz resigned for personal reasons. There was no disagreement between Dr. Schwartz and the Company. A copy of Dr. Schwartz’s resignation letter is attached to this Current Report on Form 8-K as Exhibit 17.

 

The Company is grateful to Dr. Schwartz for his services and wishes him success in all of his future endeavors.

 

Section 9 - Financial Statements and Exhibits

 

Item 9.01Financial Statements and Exhibits.

 

(c) Exhibits.

 

The following Exhibits are hereby filed as part of this Current Report on Form 8-K:

 

Exhibit

 

17Letter of Resignation of Dr. Kenneth S. Schwartz.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Ridgefield Acquisition Corp. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated: June 23, 2015

 

  Ridgefield Acquisition Corp.
  (Registrant)
   
  By: /s/ STEVEN N. BRONSON
    Steven N. Bronson,
    CEO and President